As an FDA official said that the agency has evidence that links COVID vaccines to the deaths of at least 10 children, the U.S ...

U.S. health regulators informed senior executives at Merck, Sanofi and AstraZeneca last week that their approved protective RSV treatments for infants would face fresh safety scrutiny following ...

The Food and Drug Administration (FDA) has indicated plans to conduct a fresh review of currently marketed RSV treatments for ...

U.S. regulators are reexamining infant RSV antibody treatments as safety questions surface, prompting new FDA scrutiny of ...

HealthDay News — Federal regulators have begun a safety review of two RSV medicines used to protect infants, even though no safety problems have been reported. The review covers Beyfortus (from Sanofi ...

FDA officials are newly scrutinizing several approved therapies to treat RSV in babies despite the fact that these shots were shown to be safe in clinical trials ...

The Food and Drug Administration has launched a safety review of two approved RSV drugs for infants, the latest immunizations ...

In this morning's Pharmalittle roundup, we're reading about FDA scrutiny of RSV therapies, an AI tool for clinical trials, ...

The Centers for Disease Control and Prevention's newly seated vaccine advisory committee on Thursday recommended approval for a new RSV vaccine for infants that was created by Merck. File Photo by ...

The agency also is reviewing safety of immunizations for RSV, according to manufacturers of the therapies who have been ...

(CNN) — A new slate of vaccine advisers to the US Centers for Disease Control and Prevention voted Thursday to recommend that Americans receive influenza vaccines that are free of thimerosal even ...